• Carbapenemase Gene Transmission in CREC Hospitals

  2026-09-15

  Chen et al. integrate carbapenemase-gene localization, conjugative transfer, mobile-element analysis, and clonal typing to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. The findings emphasize plasmid-associated blaNDM-1, substantial horizontal-transfer potential, and the need to interpret resistance surveillance alongside both genetic mobility and epidemiological relatedness.

• Aneugen Mechanism Profiling in 27 Reference Chemicals

  2026-09-15

  Bernacki et al. developed a tiered flow-cytometry strategy that distinguishes tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition as major mechanisms of chemical-induced aneugenicity. Its combination of fluorescent Taxol response, p-H3:Ki-67 ratios, clustering, and neural-network classification provides a practical framework for moving from genotoxicity detection to molecular-mechanism assignment.

• (-)-Blebbistatin in Cardiac Optogenetic Workflows

  2026-09-14

  Use (-)-Blebbistatin as a reversible non-muscle myosin II inhibitor to separate actomyosin mechanics from voltage readouts in advanced cardiac and cell-based assays. Combined with panoramic optical and electrical mapping, it supports more discriminating studies of contractility, cytoskeletal dynamics, and preparation-specific artifacts.

• Separating Growth Arrest from Cancer Cell Death

  2026-09-14

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a response framework that separates proliferative inhibition from cell killing and emphasizes their different proportions and timing, improving interpretation of in vitro cancer research data.

• Natural Compounds Target SARS-CoV-2 Proteins

  2026-09-13

  This 2022 Journal of Molecular Modeling study combined virtual screening, molecular docking, and molecular dynamics to evaluate natural vitamin-derived compounds against SARS-CoV-2 3CLpro and the spike receptor-binding domain. Its main contribution is a dual-target computational framework that identifies candidates for blocking both viral polyprotein processing and host-cell entry, while also highlighting the need for biochemical and cellular validation.

• Clathrin-Mediated Entry of Type III Grass Carp Reovirus

  2026-09-12

  Wang et al. used inhibitor profiling, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated route requiring endosomal acidification. The study also distinguishes Nystatin-sensitive membrane processes from the entry mechanism used by GCRV104, providing a useful framework for interpreting pharmacological entry assays.

• Polymyxin B and the LPS–Immunity Trade-Off

  2026-09-11

  Polymyxin B sulfate is more than a membrane-active antibiotic benchmark. Its ability to engage Gram-negative bacterial envelopes, influence dendritic-cell signaling, and potentially reshape interpretation of LPS biology makes it a valuable tool for translational infection, immunity, microbiome, and cancer research.

• Sulforaphane, ROS, and NLRP3 in Colitis

  2026-09-11

  A 2024 study found that Sulforaphane reduced disease-associated inflammation in dextran sodium sulfate-induced mouse colitis while suppressing oxidative stress and NLRP3 inflammasome signaling. Its combined mouse and RAW264.7 macrophage experiments support a redox-linked mechanism, but the findings remain preclinical and do not establish direct NLRP3 binding or clinical efficacy.

• Spiroplasma Entry into Drosophila S2 Cells

  2026-09-10

  Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris can invade invertebrate-derived cells, proliferate intracellularly, and induce marked cellular injury. Pharmacological and cytoskeletal perturbations identified clathrin-dependent endocytosis, dynamin activity, macropinocytosis, actin filaments, and microtubules as important components of entry and intracellular infection.

• BIRB 796: Reading p38α Signaling in Context

  2026-09-10

  BIRB 796 (Doramapimod) is a selective p38α MAPK inhibitor with unusual allosteric and kinetic properties. This article explains how to distinguish direct kinase blockade from altered dephosphorylation when interpreting inflammation, cytokine, and apoptosis assays.

• Cyanine 3-dCTP for Reliable DNA Labeling

  2026-09-09

  A scenario-based guide to using Cyanine 3-dCTP (SKU B8159) for direct fluorescent labeling of DNA and cDNA in PCR, Nick Translation, reverse-transcription, and in situ workflows. It separates established product specifications from emerging enzymatic-synthesis concepts so researchers can improve assay interpretation, reagent handling, and vendor selection.

• Cl-Amidine Workflows for PAD4 Research

  2026-09-09

  Build more informative PAD4 experiments with Cl-Amidine by pairing enzyme inhibition with histone-citrullination, viability, and immune-cell readouts. This guide covers practical formulation, assay design, translational model selection, and troubleshooting for cancer, autoimmune, and sepsis research.

• Nystatin (Fungicidin) in Cell Assays

  2026-09-08

  Learn how Nystatin (Fungicidin), SKU B1993, can support contamination-control and Candida-focused cell assay workflows without obscuring host-cell toxicity or solvent effects. This scenario-based guide connects mechanism, preparation, interpretation, and vendor-selection decisions to practical laboratory controls and cited evidence.

• DNase I (RNase-free) in RNA Vaccine Workflows

  2026-09-08

  DNase I (RNase-free) can improve RNA vaccine and molecular assay reliability by controlling residual DNA from templates, extraction, and transcription workflows. This guide connects nuclease mechanism with recent influenza RNA vaccine findings and practical sample-preparation decisions.

• Polymyxin B Sulfate in LPS and Immune Assays

  2026-09-07

  Use Polymyxin B sulfate as a membrane-active control across Gram-negative infection studies, dendritic-cell assays, and LPS-dependence experiments. This guide connects practical workflows to new microbiome–immunotherapy findings while separating validated product properties from assay-specific starting conditions.

8454 records 5/564 page Previous Next 12345 下5页 Last page